CA-MATTEL
13.11.2021 23:43:12 CET | Business Wire | Press release
The winner of the 2021 Hot Wheels™ Legends Tour was selected today during a global livestream event at Jay Leno’s Garage. Hailing from Somerset, England, the 1969 Volvo P1800 built by Lee Johnstone will join a prestigious group of custom cars in the Hot Wheels Garage of Legends™ and will be forever immortalized as a 1:64 Hot Wheels® die-cast toy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211113005258/en/
This Volvo P1800 "Aint No Saint" Gasser was originally registered as new in 1969. Its owner, 71-year-old English motor mechanic Lee Johnstone, acquired the vehicle as a rusty rolling shell before thoroughly restoring, modifying, and transforming it into the quarter-mile monster it is today. Sporting a Chevrolet 454 big block, its new power plant is capped with a 671 GMC supercharger and dual four-barrel carburetors. Finished in a fitting shade of Volvo green, it is a true culmination of more than 50 years of ‘race it, break it, build it better’ experience. Perhaps most importantly – and in true challenger spirit – "Aint No Saint" is also a family affair, with Lee's three daughters, Eleanor, Sarah and Victoria, sharing in the driving duties, and his wife, Sue, on standby to help crew.
Finishing its fourth year, the Hot Wheels Legends Tour is a worldwide competition spanning 11 countries and five continents, making it the world’s largest international traveling car show. Thousands of builds were submitted to compete in a series of in-person and virtual stops, which began in April 2021. Over the past seven months, some of the most unique and inspiring custom creations went head-to-head, all for a chance to become the next Hot Wheels die-cast toy sold – and played with by fans of all ages – across the globe.
This year’s global Grand Finale was co-hosted by celebrity car enthusiast Jay Leno and motorsports ambassador Jarod DeAnda during a virtual livestream event, where they were joined by an array of automotive and design experts from around the world to complete the task of choosing the 2021 winner. Joining them on stage were Ted Wu, Global Head of Design for Vehicles, Mattel; Bryan Benedict, Director of Vehicles Design, Mattel; Brendon Vetuskey, Vehicles Designer, Mattel; Henrik Fisker, automotive design icon; Elana Scherr, senior editor of Car and Driver; car customizer and automotive electronics guru Mad Mike; and automotive content creator and drifting enthusiast Sara Choi.
“The Hot Wheels Legends Tour has truly become a global celebration of custom car creations,” said Ted Wu, Vice President, Global Head of Design for Vehicles, Mattel. “With the addition of five new countries in the Tour, we have been able to reach and interact with millions of new fans and builders from around the world. The Volvo Gasser is a wonderful expression of authenticity, creativity and, most importantly, garage spirit. We look forward to welcoming Lee Johnstone and his 1969 Volvo P1800 into the Hot Wheels family and presenting the world with our newest Hot Wheels Legends Tour die-cast toy.”
“Having my family here with me for this moment was so special,” said Lee Johnstone. “I am excited to have my car become a Hot Wheels die-cast toy and to be able to share my passion project in 1:64 scale with the world. It’s amazing to be the first U.K. winner.”
The 2021 Hot Wheels Legends Tour was made possible in collaboration with Walmart and Mobil 1.
To learn more about the Hot Wheels Legends Tour, visit https://hotwheels.mattel.com/explore/en/legends-tour .
ABOUT HOT WHEELS
As a 53-year old brand more relevant today than ever before, Hot Wheels is the world’s leading vehicle franchise which represents and unites all segments of car culture. For decades Hot Wheels has proven its influence in automotive and pop culture with legendary design and epic performance. Through unparalleled collaborations with global leaders in streetwear, fashion, luxury, entertainment, action sports and motorsports, Hot Wheels is the #1 selling toy in the world* with over 8 billion vehicles sold. The brand engages fans of every generation through immersive live events, global competitions, theme park attractions, world-class digital gaming, consumer products and film and television content.
About Mattel
Mattel is a leading global toy company and owner of one of the strongest catalogs of children’s and family entertainment franchises in the world. We create innovative products and experiences that inspire, entertain and develop children through play. We engage consumers through our portfolio of iconic brands, including Barbie®, Hot Wheels®, Fisher-Price®, American Girl®, Thomas & Friends™, UNO® and MEGA®, as well as other popular intellectual properties that we own or license in partnership with global entertainment companies. Our offerings include film and television content, gaming, music and live events. We operate in 35 locations and our products are available in more than 150 countries in collaboration with the world’s leading retail and e-commerce companies. Since its founding in 1945, Mattel is proud to be a trusted partner in empowering children to explore the wonder of childhood and reach their full potential.
About Mobil 1
Mobil 1™ motor oil is the world's leading brand of synthetic motor oil. Our advanced technology allows Mobil 1 motor oils to meet or exceed some of the industry’s toughest standards and to provide exceptional protection under even extreme driving conditions. Mobil 1 motor oil is designed to help protect critical engine parts, maximize engine performance, and extend engine life. For more information, visit us online at www.mobil1.us or and follow @Mobil1 on Facebook, Instagram and Twitter.
*Source: The NPD Group/Retail Tracking Service
MAT-W
View source version on businesswire.com: https://www.businesswire.com/news/home/20211113005258/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release
~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom